Literature DB >> 9622767

An enzymatic assay for erythrocyte creatine as an index of the erythrocyte life time.

Y Jiao1, T Okumiya, T Saibara, E Tsubosaki, H Matsumura, K Park, K Sugimoto, T Kageoka, M Sasaki.   

Abstract

OBJECTIVES: To establish and estimate an enzymatic measurement of creatine in erythrocytes as an index of the erythrocyte life time. DESIGN AND
METHOD: The measurement of creatine in erythrocytes was performed using an enzymatic assay kit that was developed for serum and urine creatine. An erythrocyte sample was subjected to creatine measurement after hemolysis and deproteinization. Performance of the method for creatine measurement in erythrocytes was estimated. Effects of age and gender on the creatine content of erythrocytes were also estimated in 305 normal subjects.
RESULTS: The method showed within-run CVs varying from 0.7 to 1.0% (n = 20), and between-day CVs from 1.3 to 1.7% (15 days). Good linearity was observed at least up to 1000 mumol/L as creatine value in hemolyzed sample. The analytical recovery was calculated to be 98.1 +/- 1.3% on average. No considerable interference by various substances, including guanidino compounds and amino acids, with the assay was observed. Excellent correlation was observed between the present method and high performance liquid chromatography. With the unit of mumol/g Hb: slope, 1.034 +/- 0.003 (mean +/- SD); intercept, -0.059 +/- 0.012 (mean +/- SD); correlation coefficient, 0.9996; and Sy.x, 0.069. With the unit of mumol/L RBC: slope, 1.033 +/- 0.003 (mean +/- SD); intercept, -18.23 +/- 3.55 (mean +/- SD); correlation coefficient 0.9996; and Sy.x, 20.40. A significant increase in erythrocyte creatine was observed in females aged 11- to 50 years old as compared with males in the corresponding age bracket, however, a gender difference was not observed in other age bracket. This finding suggests the possibility of a slight decrease in the erythrocyte life time due to menstruation in females.
CONCLUSION: This study showed that the present method is favorable for quantifying erythrocyte creatine, and has analytical characteristics suitable for routine work in clinical laboratories.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622767     DOI: 10.1016/s0009-9120(97)00164-1

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis.

Authors:  Dhouha Darghouth; Bérengère Koehl; Jean François Heilier; Geoffrey Madalinski; Petra Bovee; Giel Bosman; Jean Delaunay; Christophe Junot; Paul-Henri Roméo
Journal:  Haematologica       Date:  2011-08-22       Impact factor: 9.941

2.  Kinetics of creatine ingested as a food ingredient.

Authors:  Louise Deldicque; Jacques Décombaz; Hermann Zbinden Foncea; Jacques Vuichoud; Jacques R Poortmans; Marc Francaux
Journal:  Eur J Appl Physiol       Date:  2007-09-13       Impact factor: 3.078

3.  Influence of Iron Deficiency on HbA1c Levels in Pregnant Women: Comparison with Non-Pregnant Women.

Authors:  Kunihiko Hashimoto; Masafumi Koga
Journal:  J Clin Med       Date:  2018-02-20       Impact factor: 4.241

4.  Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients.

Authors:  Shun Hasegawa; Seishi Nakamura; Tetsuro Sugiura; Yoshiaki Tsuka; Nobuyuki Takahashi; Koichiro Matsumura; Toshika Okumiya; Masato Baden; Ichiro Shiojima
Journal:  BMC Nephrol       Date:  2021-12-12       Impact factor: 2.388

5.  Diminution of Oxidative Damage to Human Erythrocytes and Lymphocytes by Creatine: Possible Role of Creatine in Blood.

Authors:  Neha Qasim; Riaz Mahmood
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

6.  Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study.

Authors:  Koichiro Matsumura; Toshika Okumiya; Tetsuro Sugiura; Nobuyuki Takahashi; Yoshihiro Yamamoto; Sanae Kikuchi; Kenichi Fujii; Munemitsu Otagaki; Ichiro Shiojima
Journal:  BMC Nephrol       Date:  2020-09-29       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.